Nucleosides - RNA / BOC Sciences

2'-O-(2-Methoxyethyl)cytidine

Description: It is a cytidine derivative as a building block for crosslinking oligonucleotides.

CAT: BRP-00314

CAS: 223777-16-0

MF: C12H19N3O6

MF: 301.30

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 1.57±0.1 g/cm3 (Predicted)

Boiling Point: 535.3±60.0°C (Predicted)

InChIKey: YKOGMMXZKKVMBT-QCNRFFRDSA-N

CanonicalSMILES: COCCOC1C(C(OC1N2C=CC(=NC2=O)N)CO)O

IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]pyrimidin-2-one

InChI: InChI=1S/C12H19N3O6/c1-19-4-5-20-10-9(17)7(6-16)21-11(10)15-3-2-8(13)14-12(15)18/h2-3,7,9-11,16-17H,4-6H2,1H3,(H2,13,14,18)/t7-,9-,10-,11-/m1/s1

Synonyms: Cytidine, 2'-O-(2-methoxyethyl)-; 4-amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 2'-O-methoxyethylcytidine; 2'-O-MOE Cytidine; 2'-O-MOE-rC

N2-Isobutyryl-2',3'-diacetylguanosine

Description: N2-Isobutyryl-2',3'-diacetylguanosine is an essential biomedical compound, exhibiting unparalleled potential in arresting cancer cell proliferation and thwarting viral replication.

CAT: BRP-00316

CAS: 163586-86-5

MF: C18H23N5O8

MF: 437.40

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.62±0.1 g/cm3

InChIKey: HWVKXBNLKJAPSV-CNEMSGBDSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)OC(=O)C)OC(=O)C

IUPAC Name: [(2R,3R,4R,5R)-4-acetyloxy-2-(hydroxymethyl)-5-[2-(2-methylpropanoylamino)-6-oxo-1H-purin-9-yl]oxolan-3-yl] acetate

InChI: InChI=1S/C18H23N5O8/c1-7(2)15(27)21-18-20-14-11(16(28)22-18)19-6-23(14)17-13(30-9(4)26)12(29-8(3)25)10(5-24)31-17/h6-7,10,12-13,17,24H,5H2,1-4H3,(H2,20,21,22,27,28)/t10-,12-,13-,17-/m1/s1

Synonyms: N2-iBu-2',3'-Acetyl-Guanosine; N-Isobutyryl-2',3'-Acetyl-Guanosine; Guanosine-9-17N, N-(2-methyl-1-oxopropyl)-, 2',3'-diacetate; N-(2-Methyl-1-oxopropyl)guanosine, 2',3'-diacetate; 2',3'-Diacetyl Guanosine (n-ibu)

2'-O-(2-Methoxyethyl)inosine

Description: 2'-O-(2-Methoxyethyl)inosine is a potent nucleoside analog widely used in biomedical research and drug development. It exhibiting antiviral activity against RNA viruses such as influenza and hepatitis C. Additionally, it has shown promising potential in the reserch of various cancers, including colorectal and liver cancer.

CAT: BRP-00349

CAS: 545374-76-3

MF: C13H18N4O6

MF: 326.31

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

InChIKey: YVCRYUJBJVEBAK-QYVSTXNMSA-N

CanonicalSMILES: COCCOC1C(C(OC1N2C=NC3=C2N=CNC3=O)CO)O

IUPAC Name: 9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one

InChI: InChI=1S/C13H18N4O6/c1-21-2-3-22-10-9(19)7(4-18)23-13(10)17-6-16-8-11(17)14-5-15-12(8)20/h5-7,9-10,13,18-19H,2-4H2,1H3,(H,14,15,20)/t7-,9-,10-,13-/m1/s1

Synonyms: 2'-O-MOE-rI; 2'-o-methoxyethyl inosine; Inosine, 2'-O-(2-methoxyethyl)-; 9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-1H-purin-6-one

5-Methylcytidine

Description: 5-Methylcytidine is a derivative of Cytidine, found in ribonucleic acids of animals, plants and bacteria. 5-Methylcytidine is a nucleoside found in liver emulsion that can inhibit the growth of spontaneous tumors of mammary gland origin in mice. 5-Methylcytidine is one of many nucleosides that can be used as biomedical marker using liquid chromatography and ion trap mass spectrometry coupling.

CAT: BRP-00350

CAS: 2140-61-6

MF: C10H15N3O5

MF: 257.24

Purity: ≥98% by HPLC

Appearance: Off-white to pale beige solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, under inert atmosphere

Density: 1.79±0.1 g/cm³

Melting Point: 212-215 °C (dec.)

Boiling Point: 537.5±60.0 °C (Predicted)

Symbol: m⁵C

InChIKey: ZAYHVCMSTBRABG-JXOAFFINSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly), Water (Sparingly)

CanonicalSMILES: CC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one

InChI: InChI=1S/C10H15N3O5/c1-4-2-13(10(17)12-8(4)11)9-7(16)6(15)5(3-14)18-9/h2,5-7,9,14-16H,3H2,1H3,(H2,11,12,17)/t5-,6-,7-,9-/m1/s1

Synonyms: 5-Me-rC; 5-Methyl-cytidine; 4-amino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one; NSC 363933; 5-Methyl-D-cytidine; 5-Methyl-ribo Cytidine

N4-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine

Description: N4-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine, an extraordinary compound utilized in the biomedical sector, showcases robust antiviral properties. Its efficacy is notably significant against RNA viruses such as respiratory syncytial virus (RSV) and coronaviruses. By selectively inhibiting viral replication through the precise targeting of viral RNA polymerases, it presents itself as a compelling contender for the advancement of groundbreaking antiviral therapeutics. With its multifaceted mechanisms of action, this compound holds immense promise in the realm of cutting-edge antiviral research and development.

CAT: BRP-00351

CAS: 340162-93-8

MF: C20H25N3O7

MF: 419.43

Purity: ≥95%

Appearance: White, off-white to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, Keep in a dark and dry place

Density: 1.41±0.1 g/cm3

InChIKey: LGGHYGUGIGYDFX-YKTARERQSA-N

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)CO)O)OCCOC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C20H25N3O7/c1-12-10-23(19-16(29-9-8-28-2)15(25)14(11-24)30-19)20(27)22-17(12)21-18(26)13-6-4-3-5-7-13/h3-7,10,14-16,19,24-25H,8-9,11H2,1-2H3,(H,21,22,26,27)/t14-,15-,16-,19-/m1/s1

Synonyms: N-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine; N-(1-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; Cytidine, N-benzoyl-2'-O-(2-methoxyethyl)-5-methyl-; 2'-O-MOE-5-Me-rC(Bz); N4-Bz-5-Me-2'-O-MOE-C; N4-benzoyl-5-methyl-2'-O-methoxyethylcytidine

N6-Benzoyl-2'-O,4'-C-methyleneadenosine

Description: N6-Benzoyl-2'-O,4'-C-methyleneadenosine, a highly efficacious agent employed in the realm of biomedicine due to its remarkable anticancer attributes, stands out in the selective eradication of malignant cells via the potent suppression of neoplastic cell proliferation and the initiation of programmed cell death. Notably, this product holds immense potential for the advancement of avant-garde therapeutic strategies devoted to diverse cancer types, encompassing breast, lung, and prostate cancer. Its exceptional mode of action lies in the targeted inhibition of specific enzymes and pathways vital in the malignant cascade, rendering it an exceedingly auspicious contender for antineoplastic interventions.

CAT: BRP-00352

CAS: 209968-94-5

MF: C18H17N5O5

MF: 383.36

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.7±0.1 g/cm3

InChIKey: LWLHBOKWFIOXPA-OBQMCUGOSA-N

CanonicalSMILES: C1C2(C(C(O1)C(O2)N3C=NC4=C(N=CN=C43)NC(=O)C5=CC=CC=C5)O)CO

IUPAC Name: N-[9-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]purin-6-yl]benzamide

InChI: InChI=1S/C18H17N5O5/c24-6-18-7-27-12(13(18)25)17(28-18)23-9-21-11-14(19-8-20-15(11)23)22-16(26)10-4-2-1-3-5-10/h1-5,8-9,12-13,17,24-25H,6-7H2,(H,19,20,22,26)/t12-,13+,17-,18+/m1/s1

Synonyms: 9-[2,5-Anhydro-4-(hydroxymethyl)-α-L-lyxofuranosyl]-N-benzoyl-9H-purin-6-amine; (1S,3R,4R,7S)-7-Hydroxy-1-hydroxymethyl-3-(6-N-benzoyladenin-9-yl)-2,5-dioxabicyclo-[2.2.1]heptane; LNA-A(Bz); (1S,3R,4R,7S)-3-(6-N-benzoyladenine-9-yl)-7-hydroxy-1-hydroxymethyl-2,5-dioxabicyclo[2.2.1]heptane; 2'-O-4'-C-Locked-rA(Bz)

2'-Deoxy-L-uridine

Description: 2'-Deoxy-L-uridine is a valuable nucleoside analogue commonly used in the biomedical industry playing a crucial role in the research and development of RNA and DNA.

CAT: BRP-00353

CAS: 31501-19-6

MF: C9H12N2O5

MF: 228.20

Purity: ≥95% by HPLC

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.533±0.06 g/cm3(Predicted)

InChIKey: MXHRCPNRJAMMIM-CHKWXVPMSA-N

CanonicalSMILES: C1C(C(OC1N2C=CC(=O)NC2=O)CO)O

IUPAC Name: 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m1/s1

Synonyms: 1-((2S,4R,5S)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; L-2'-dU; 1-(2-Deoxy-β-L-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione; Uracil, 1-(2-deoxy-β-L-erythro-pentofuranosyl)-; 2'-Deoxy-β-L-uridine

Related CAS: 189282-17-5 (1-(2-Deoxy-α-L-erythro-pentofuranosyl)-2,4(1H,3H)-pyrimidinedione)

2'-O-Propargyluridine

Description: This cutting-edge product, 2'-O-Propargyluridine, plays a pivotal role in the realm of biomedicine. It serves as a crucial component in the treatment and comprehension of diverse diseases. Specifically, this modified nucleoside exhibits the exceptional ability to integrate into RNA molecules, thereby facilitating the exploration of RNA's intricate structure and functionality. Furthermore, this remarkable compound finds application in the development of antiviral medications, functioning as an invaluable research instrument for unraveling the complexities of RNA biology and viral replication mechanisms.

CAT: BRP-00354

CAS: 129778-58-1

MF: C12H14N2O6

MF: 282.25

Purity: 97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

InChIKey: SJIYVXTZWZSVLZ-QCNRFFRDSA-N

CanonicalSMILES: C#CCOC1C(C(OC1N2C=CC(=O)NC2=O)CO)O

IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-ynoxyoxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C12H14N2O6/c1-2-5-19-10-9(17)7(6-15)20-11(10)14-4-3-8(16)13-12(14)18/h1,3-4,7,9-11,15,17H,5-6H2,(H,13,16,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 2'-O-2-Propyn-1-yluridine; 2'-O-Propargyl-D-uridine; 2'-O-propargyl-rU; 1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 2'-O-propargyl-uridine; 2'-O-propargyl-Ur; 2'-(O-propargyl) Uridine

N4-Benzoyl-2'-O-propargyladenosine

Description: N4-Benzoyl-2'-O-propargyladenosine is a versatile biomedical compound, used for studying diverse viral infections, encompassing notorious culprits like HIV and herpes viruses. Its unrivaled potence resides in the ability to hamper viral replication.

CAT: BRP-00355

CAS: 210096-44-9

MF: C20H19N5O5

MF: 409.40

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.49±0.1 g/cm3

InChIKey: ADMKUOVXGJZAMV-KHTYJDQRSA-N

CanonicalSMILES: C#CCOC1C(C(OC1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)O

IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-ynoxyoxolan-2-yl]purin-6-yl]benzamide

InChI: InChI=1S/C20H19N5O5/c1-2-8-29-16-15(27)13(9-26)30-20(16)25-11-23-14-17(21-10-22-18(14)25)24-19(28)12-6-4-3-5-7-12/h1,3-7,10-11,13,15-16,20,26-27H,8-9H2,(H,21,22,24,28)/t13-,15-,16-,20-/m1/s1

Synonyms: N6-Benzoyl-2'-O-(2-propyn-1-yl)adenosine; N4-Benzoyl-2'-O-(2-propyn-1-yl)adenosine; N-(9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; 2'-O-(1-propyn-3-yl)-6-N-benzoyladenosine; Adenosine, N-benzoyl-2'-O-2-propyn-1-yl-; 2'-O-propargyl-rA(Bz); N-Benzoyl-2'-O-2-propyn-1-yladenosine; N-Benzoyl-2'-O-propargyladenosine; N6-Bz-2'-O-propargyl-Ar; N6-Bz-2'-O-propargyl-adenosine

N2-iso-Butyroyl-2'-O-propargylguanosine

Description: N2-iso-Butyroyl-2'-O-propargylguanosine, an indispensable pharmaceutical compound employed in the biomedical sector, manifests substantial prospects for antiviral drug advancement. It displays commendable efficacy against RNA virus-induced infections, rendering it valuable in combating diseases encompassing hepatitis C and respiratory syncytial viruses.

CAT: BRP-00356

CAS: 2095417-55-1

MF: C17H21N5O6

MF: 391.38

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.56±0.1 g/cm3

InChIKey: NAZLVNVVZNYAAV-UBEDBUPSSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)OCC#C

IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-ynoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C17H21N5O6/c1-4-5-27-12-11(24)9(6-23)28-16(12)22-7-18-10-13(22)19-17(21-15(10)26)20-14(25)8(2)3/h1,7-9,11-12,16,23-24H,5-6H2,2-3H3,(H2,19,20,21,25,26)/t9-,11-,12-,16-/m1/s1

Synonyms: 2'-O-propargyl-rG(iBu); N-(9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide; N2-iBu-2'-O-propargyl-Gr; N2-iBu-2'-O-propargyl-guanosine

N4-Benzoyl-2'-O-(2-methoxyethyl)cytidine

Description: N4-Benzoyl-2'-O-(2-methoxyethyl)cytidine, hailed as an efficacious and potent antiviral compound, is widely used for studying notorious Herpes Simplex Virus type 1 (HSV-1) and Hepatitis C Virus (HCV).

CAT: BRP-00357

CAS: 2305416-18-4

MF: C19H23N3O7

MF: 405.40

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.44±0.1 g/cm3 (Predicted)

InChIKey: VDTLYOJAWYZWEE-GFOCRRMGSA-N

CanonicalSMILES: COCCOC1C(C(OC1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)CO)O

IUPAC Name: N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C19H23N3O7/c1-27-9-10-28-16-15(24)13(11-23)29-18(16)22-8-7-14(21-19(22)26)20-17(25)12-5-3-2-4-6-12/h2-8,13,15-16,18,23-24H,9-11H2,1H3,(H,20,21,25,26)/t13-,15-,16-,18-/m1/s1

Synonyms: 2'-O-MOE-rC(Bz); N-(1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

2'-O-Propargylcytidine

Description: 2'-O-Propargylcytidine, a compound of utmost importance in the biomedical sector, serves as an indispensable agent in combatting a myriad of afflictions. Garnering wide-ranging acclaim, it displays promising potential in thwarting the proliferation of menacing viruses like SARS-CoV and MERS-CoV. Furthermore, its notable efficacy in addressing diverse manifestations of neoplasms, notably pulmonary and mammary carcinoma, instills hope and marks it as a prime contender for the synthesis of revolutionary antiviral and anticarcinogenic therapeutics.

CAT: BRP-00358

CAS: 206552-85-4

MF: C12H15N3O5

MF: 281.26

Purity: ≥95% by HPLC

Appearance: White crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.51±0.1 g/cm3

Boiling Point: 544.7±60.0 °C at 760 mmHg

InChIKey: FJGRSBJPLPTKDE-QCNRFFRDSA-N

Solubility: Soluble in Methanol

CanonicalSMILES: C#CCOC1C(C(OC1N2C=CC(=NC2=O)N)CO)O

IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-ynoxyoxolan-2-yl]pyrimidin-2-one

InChI: InChI=1S/C12H15N3O5/c1-2-5-19-10-9(17)7(6-16)20-11(10)15-4-3-8(13)14-12(15)18/h1,3-4,7,9-11,16-17H,5-6H2,(H2,13,14,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 2'-O-propargyl-rC; 2'-O-Propargyl-D-cytidine; 4-amino-1-[(2-O-propargyl)-β-D-ribofuranosyl]-2H-pyrimidin-2-one; 2'-(O-Propargyl)-cytidine; 2'-O-2-Propyn-1-ylcytidine; Cytidine, 2'-O-2-propynyl-; 2'-(O-propargyl) Cytidine

2'-O-(2-Propyn-1-yl)adenosine

Description: 2'-O-(2-Propyn-1-yl)adenosine is a revolutionary modified adenosine derivative that has been extensively utilized in studying a multitude of ailments, encompassing cancer, viral infections and neurological disorders.

CAT: BRP-00359

CAS: 151390-97-5

MF: C13H15N5O4

MF: 305.29

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.65±0.1 g/cm3 (Predicted)

Boiling Point: 655.1±65.0°C (Predicted)

InChIKey: ROHGEAZREAFNTO-QYVSTXNMSA-N

CanonicalSMILES: C#CCOC1C(C(OC1N2C=NC3=C(N=CN=C32)N)CO)O

IUPAC Name: (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-prop-2-ynoxyoxolan-3-ol

InChI: InChI=1S/C13H15N5O4/c1-2-3-21-10-9(20)7(4-19)22-13(10)18-6-17-8-11(14)15-5-16-12(8)18/h1,5-7,9-10,13,19-20H,3-4H2,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1

Synonyms: 2'-O-propargyl-rA; 2'-O-Propargyladenosine; 2'-O-2-propynyl-Adenosine; (2R,3R,4R,5R)-5-(6-Amino-9H-purin-9-yl)-2-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-3-ol; 2'-O-2-Propyn-1-yladenosine; 2'-O-propargyl-adenosine; 2'-Propargyladenosine; 2'-O-propargyl-2-amino-Ar; 2'-O-2-Propyn-1-yladenosine; Adenosine, 2'-O-2-propynyl-; 2'-O-(1-Propyn-3-yl)adenosine; 2'-(O-propargyl) Adenosine

2'-O-Propygylguanosine

Description: 2'-O-Propygylguanosine is a crucial compound extensively used in the biomedicine industry. This product acts as an antiviral agent, primarily targeting viral infections caused by RNA viruses. It demonstrates promising therapeutic potential in treating diseases like HIV, Ebola, and hepatitis C. Its unique structure and mechanism of action make it an invaluable tool in the fight against these life-threatening viral infections.

CAT: BRP-00360

CAS: 206552-86-5

MF: C13H15N5O5

MF: 321.29

Purity: ≥95%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.8±0.1 g/cm3

Boiling Point: 737.5±70.0°C at 760 mmHg

InChIKey: VBIXIAQUDWOPDT-WOUKDFQISA-N

CanonicalSMILES: C#CCOC1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)CO)O

IUPAC Name: 2-amino-9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-prop-2-ynoxyoxolan-2-yl]-1H-purin-6-one

InChI: InChI=1S/C13H15N5O5/c1-2-3-22-9-8(20)6(4-19)23-12(9)18-5-15-7-10(18)16-13(14)17-11(7)21/h1,5-6,8-9,12,19-20H,3-4H2,(H3,14,16,17,21)/t6-,8-,9-,12-/m1/s1

Synonyms: 2'-O-propargyl-rG; 2'-O-(2-Propyn-1-yl)guanosine; 2'-O-Propargyl-guanosine; 2-Amino-9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one; 2'-O-2-Propyn-1-ylguanosine; 2'-O-propargyl-Gr; 2'-(O-Propargyl)-guanosine; 2'-(O-propargyl) Guanosine

N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine

Description: N6-Benzoyl-5'-O-DMT-3'-O-methyladenosine is a remarkable biomedical compound possessing anti-inflammatory and anticancer properties.

CAT: BRP-00362

CAS: 127212-38-8

MF: C39H37N5O7

MF: 687.74

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.3±0.1 g/cm3

InChIKey: BXARQKKKQMVIEG-CJEGOSRCSA-N

CanonicalSMILES: COC1C(OC(C1O)N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC

IUPAC Name: N-[9-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-hydroxy-4-methoxyoxolan-2-yl]purin-6-yl]benzamide

InChI: InChI=1S/C39H37N5O7/c1-47-29-18-14-27(15-19-29)39(26-12-8-5-9-13-26,28-16-20-30(48-2)21-17-28)50-22-31-34(49-3)33(45)38(51-31)44-24-42-32-35(40-23-41-36(32)44)43-37(46)25-10-6-4-7-11-25/h4-21,23-24,31,33-34,38,45H,22H2,1-3H3,(H,40,41,43,46)/t31-,33-,34-,38-/m1/s1

Synonyms: 5'-O-DMTr-3'-O-Me-rA(Bz); N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-methyladenosine; N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-hydroxy-4-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-3'-O-methyladenosine

2',3'-Di-O-methyladenosine

Description: 2',3'-Di-O-methyladenosine, a compound of utmost importance, finds extensive utility in the biomedical field owing to its immense potential for therapeutic purposes. In the realm of disease management, particularly in cancer, neurodegenerative disorders, and viral infections, this product assumes a pivotal role. Its remarkable chemical composition and distinct pharmacological characteristics render it an exceedingly propitious contender for targeted pharmaceutical administration and individualized medical interventions.

CAT: BRP-00363

CAS: 20649-46-1

MF: C12H17N5O4

MF: 295.29

Purity: ≥98% by HPLC

Appearance: White solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C, under inert atmosphere

Density: 1.66±0.1 g/cm3

Melting Point: 167-172 °C

Boiling Point: 553.4±60.0 °C at 760 mmHg

InChIKey: YLTDWADIGWTCSP-WOUKDFQISA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly)

CanonicalSMILES: COC1C(OC(C1OC)N2C=NC3=C(N=CN=C32)N)CO

IUPAC Name: [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dimethoxyoxolan-2-yl]methanol

InChI: InChI=1S/C12H17N5O4/c1-19-8-6(3-18)21-12(9(8)20-2)17-5-16-7-10(13)14-4-15-11(7)17/h4-6,8-9,12,18H,3H2,1-2H3,(H2,13,14,15)/t6-,8-,9-,12-/m1/s1

Synonyms: 2',3'-O-Me-rA; Adenosine, 2',3'-di-O-methyl-; ((2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dimethoxytetrahydrofuran-2-yl)methanol; 2',3'-Dimethoxyadenosine

N6-Benzoyl-3'-O-methyladenosine

Description: N6-Benzoyl-3'-O-methyladenosine, a modified nucleoside, plays a vital role in biomedicine research by uncovering the intricate pathways of RNA modification and its impact on the onset of disease. It has sparked significant interest due to its potential application as a therapeutic tool in cancer and other diseases by regulating gene expression. The interaction of this compound with specific enzymes involved in RNA processing and modification elucidates the complexity of these biological processes, making it a precious commodity in the research field.

CAT: BRP-00364

CAS: 85090-30-8

MF: C18H19N5O5

MF: 385.37

Purity: 96%

Appearance: White to Off-white Powder to Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.59±0.1 g/cm3 (Predicted)

InChIKey: MCFYIRSCNBGQBD-XWXWGSFUSA-N

CanonicalSMILES: COC1C(OC(C1O)N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO

IUPAC Name: N-[9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]purin-6-yl]benzamide

InChI: InChI=1S/C18H19N5O5/c1-27-14-11(7-24)28-18(13(14)25)23-9-21-12-15(19-8-20-16(12)23)22-17(26)10-5-3-2-4-6-10/h2-6,8-9,11,13-14,18,24-25H,7H2,1H3,(H,19,20,22,26)/t11-,13-,14-,18-/m1/s1

Synonyms: N6-Benzoyl-3'-O-methyl-D-adenosine; N-Benzoyl-3'-O-methyladenosine; N-(9-((2R,3R,4S,5R)-3-Hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide; 3'-O-Me-rA(Bz)

3'-O-TBDMS-2'-O-Me-rG(iBu)

Description: Guanosine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl) - the nucleoside analog believed to hold great potential in the fight against a wide range of viral infections and certain cancers. Extensively researched for its ability to disrupt viral or cancerous DNA replication, Guanosine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl) has been shown to be effective against HCV, HIV, herpes simplex virus, leukemia and lung cancer - making it a powerful tool in the battle against these debilitating diseases.

CAT: BRP-00365

CAS: 863097-97-6

MF: C21H35N5O6Si

MF: 481.62

Purity: ≥98% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.32±0.1 g/cm3

InChIKey: CEEYEENCDIBWAI-QEPJRFBGSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O[Si](C)(C)C(C)(C)C)OC

IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[tert-butyl(dimethyl)silyl]oxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C21H35N5O6Si/c1-11(2)17(28)24-20-23-16-13(18(29)25-20)22-10-26(16)19-15(30-6)14(12(9-27)31-19)32-33(7,8)21(3,4)5/h10-12,14-15,19,27H,9H2,1-8H3,(H2,23,24,25,28,29)/t12-,14-,15-,19-/m1/s1

Synonyms: 3'-O-[(1,1-Dimethylethyl)dimethylsilyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)guanosine; Guanosine, 3'-O-[(1,1-dimethylethyl)dimethylsilyl]-2'-O-methyl-N-(2-methyl-1-oxopropyl)-; N-(9-((2R,3R,4R,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-3H-purin-2-yl)isobutyramide

Related CAS: 1345716-51-9 (Deleted CAS) ; 2919005-85-7 (Deleted CAS)

N-Butyl Molnupiravir

Description: An impurity of Molnupiravir which is an antiviral drug with promising activity against the SARS-CoV-2 virus.

CAT: BRP-00367

CAS: 2770244-32-9

MF: C13H19N3O7

MF: 329.31

Purity: ≥98% by HPLC

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.61±0.1 g/cm3

InChIKey: UFRPBGZCTRKUTJ-FAQVLOEFSA-N

CanonicalSMILES: CCCC(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O

IUPAC Name: [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl butanoate

InChI: InChI=1S/C13H19N3O7/c1-2-3-9(17)22-6-7-10(18)11(19)12(23-7)16-5-4-8(15-21)14-13(16)20/h4-5,7,10-12,18-19,21H,2-3,6H2,1H3,(H,14,15,20)/t7-,10-,11-,12-/m1/s1

Synonyms: N4-OH-5'-O-Butyryl-rC; ((2R,3S,4R,5R)-3,4-dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl butyrate

Tetrahydrouridine

Description: Tetrahydrouridine, a derivative of Uridine, is a potent and reversible competitive inhibitor of cytidine deaminase (CDD) (Ki values = 54 and 240 nM for human and E. coli enzymes, respectively). Tetrahydrouridine has the potential to treat tumors with highly expressed CDA as it inhibits cell proliferation through cell cycle regulation despite of cytidine deaminase expression levels deaminase (CDA). Used in combination with cytosine arabinoside (Ara-C) to assess the anti-leukemic activity and anti-tumor activity of Ara-C in in vitro studies.

CAT: BRP-00368

CAS: 18771-50-1

MF: C9H16N2O6

MF: 248.23

Purity: 95%

Appearance: Solid powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.622±0.06 g/cm3

Boiling Point: 668.6±55.0 °C at 760 mmHg

Application: Antimetabolites

InChIKey: UCKYOOZPSJFJIZ-XVKVHKPRSA-N

CanonicalSMILES: C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O

IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one

InChI: 1S/C9H16N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h4-8,12-15H,1-3H2,(H,10,16)/t4-,5?,6-,7-,8-/m1/s1

Synonyms: 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one; NSC 112907; NSC-112907; NSC112907; 2(1H)-Pyrimidinone, tetrahydro-4-hydroxy-1-β-D-ribofuranosyl-; 3,4,5,6-Tetrahydrouridine; 1-(β-D-Ribofuranosyl)-4-hydroxytetrahydro-1(1H)-pyrimidinone